Brickell Stock Buy Hold or Sell Recommendation

BBI
 Stock
  

USD 0.10  0.03  23.08%   

Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Brickell Biotech is 'Cautious Hold'. Macroaxis provides Brickell Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBI positions. The advice algorithm takes into account all of Brickell Biotech's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Brickell Biotech's buy-and-hold perspective. Continue to Brickell Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Brickell and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Brickell Biotech.

Execute Brickell Biotech Buy or Sell Advice

The Brickell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brickell Biotech. Macroaxis does not own or have any residual interests in Brickell Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brickell Biotech's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Brickell BiotechBuy Brickell Biotech
Sell

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very LowDetails

Economic Sensitivity

Responds to the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Brickell Biotech has a Mean Deviation of 6.19, Standard Deviation of 9.68 and Variance of 93.67
We provide trade advice to complement the prevailing expert consensus on Brickell Biotech. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Brickell Biotech is not overpriced, please confirm all Brickell Biotech fundamentals, including its number of shares shorted, ebitda, current ratio, as well as the relationship between the price to sales and cash per share . As Brickell Biotech appears to be a penny stock we also recommend to validate its price to book numbers.

Brickell Biotech Trading Alerts and Improvement Suggestions

Brickell Biotech generated a negative expected return over the last 90 days
Brickell Biotech has high historical volatility and very poor performance
Brickell Biotech has some characteristics of a very speculative penny stock
Brickell Biotech was previously known as BRICKELL BIOTECH INC and was traded on NASDAQ Exchange under the symbol VICL.
The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 26.88 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Brickell Biotech has a frail financial position based on the latest SEC disclosures
Latest headline from www.nasdaq.com: Why Crypto Investors Should Want Regulation - Nasdaq

Brickell Biotech current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brickell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brickell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price2.67
Target Median Price2.00
Target High Price4.00
Recommendation Mean1.50
Number Of Analyst Opinions3
Target Low Price2.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Brickell Biotech Returns Distribution Density

The distribution of Brickell Biotech's historical returns is an attempt to chart the future uncertainty of Brickell Biotech's future price movements. The chart of the probability distribution of Brickell Biotech stock daily returns describes the distribution of returns around its average expected value. We use Brickell Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Brickell Biotech returns is essential to provide solid investment advice for Brickell Biotech stock.
Mean Return-1.05Value At Risk-16.22
Potential Upside13.33Standard Deviation9.68
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Brickell Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Brickell Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Brickell Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brickell Biotech backward and forwards among themselves. Brickell Biotech's institutional investor refers to the entity that pools money to purchase Brickell Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares3.1 M832 K
Telemetry Investments LlcCommon Shares1.9 M510 K
Renaissance Technologies LlcCommon Shares1.4 M380 K
Palisade Capital Management LlcCommon Shares970.5 K260 K
Geode Capital Management LlcCommon Shares627.3 K167 K
Blackrock IncCommon Shares215.7 K57 K
Citadel Advisors LlcCommon Shares137.4 K37 K
Note, although Brickell Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Brickell Biotech Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(80 K)(12 K)(7 K)(23 K)(36 K)(38.84 K)
Depreciation Amortization and Accretion793 K49 K28 K10 K22 K22.58 K
Net Cash Flow or Change in Cash and Cash Equivalents16.65 M2.67 M(835 K)22.88 M(3.23 M)(3.32 M)
Issuance Purchase of Equity Shares30.55 M45 K47 K38 M33 M35.61 M
Net Cash Flow from Financing30.55 M(1.29 M)2.64 M38.44 M32.95 M35.55 M
Net Cash Flow from Investing(5.29 M)(12 K)32.51 M4.48 M(36 K)(36.95 K)
Net Cash Flow Investment Acquisitions and Disposals(7.42 M)(5.21 M)19.5 M4.5 M5.17 M5.58 M
Net Cash Flow from Operations(8.6 M)3.97 M(35.98 M)(20.03 M)(36.15 M)(37.1 M)
Share Based Compensation756 K711 K1.53 M1.99 M2.26 M2.08 M

Brickell Biotech Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Brickell Biotech or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Brickell Biotech stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Brickell stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.81
β
Beta against DOW1.31
σ
Overall volatility
9.86
Ir
Information ratio -0.09

Brickell Biotech Volatility Alert

Brickell Biotech is displaying above-average volatility over the selected time horizon. Investors should scrutinize Brickell Biotech independently to ensure intended market timing strategies are aligned with expectations about Brickell Biotech volatility. Brickell Biotech is a potential penny stock. Although Brickell Biotech may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Brickell Biotech. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Brickell instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Brickell Biotech Fundamentals Vs Peers

Comparing Brickell Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Brickell Biotech's direct or indirect competition across all of the common fundamentals between Brickell Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Brickell Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Brickell Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Brickell Biotech by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Brickell Biotech to competition
FundamentalsBrickell BiotechPeer Average
Return On Equity(151.70) %(0.31) %
Return On Asset(79.41) %(0.14) %
Current Valuation(1.75 M)16.62 B
Shares Outstanding115.05 M571.82 M
Shares Owned by Insiders1.31 %10.09 %
Shares Owned by Institutions17.27 %39.21 %
Number of Shares Shorted4.21 M4.71 M
Price to Earning(35.16) X28.72 X
Price to Book0.44 X9.51 X
Price to Sales27.91 X11.42 X
Revenue404 K9.43 B
Gross Profit(27.83 M)27.38 B
EBITDA(40.22 M)3.9 B
Net Income(39.47 M)570.98 M
Cash and Equivalents26.88 M2.7 B
Cash per Share0.22 X5.01 X
Total Debt69 K5.32 B
Debt to Equity0.002 %48.70 %
Current Ratio6.15 X2.16 X
Book Value Per Share0.22 X1.93 K
Cash Flow from Operations(36.15 M)971.22 M
Short Ratio0.54 X4.00 X
Earnings Per Share(0.62) X3.12 X
Number of Employees1618.84 K
Beta0.11-0.15
Market Capitalization11.27 M19.03 B
Total Asset59.37 M29.47 B
Retained Earnings(91.69 M)9.33 B
Working Capital47.05 M1.48 B
Current Asset52.66 M9.34 B
Current Liabilities5.61 M7.9 B
Z Score96.48.72
   Acquisition by Veru Dennison T of 65000 shares of Brickell Biotech subject to Rule 16b-3 [view details]

About Brickell Biotech Buy or Sell Advice

When is the right time to buy or sell Brickell Biotech? Buying financial instruments such as Brickell Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Brickell Biotech investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets17.97 M33.53 M29.6 M34.99 M
Total Assets18.14 M33.63 M29.72 M37.17 M

Use Investing Ideas to Build Portfolios

In addition to having Brickell Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Long-Short Thematic Idea Now

Long-Short
Long-Short Theme
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long-Short theme has 1 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long-Short Theme or any other thematic opportunities.
View All  Next Launch Long-Short
Continue to Brickell Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
11.7 M
Quarterly Revenue Growth YOY
4.41
Return On Assets
-0.85
Return On Equity
-1.76
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.